Literature DB >> 2076905

Persistence of Borrelia burgdorferi and histopathological alterations in experimentally infected animals. A comparison with histopathological findings in human Lyme disease.

V Preac Mursic1, E Patsouris, B Wilske, S Reinhardt, B Gross, P Mehraein.   

Abstract

Gerbils appear to be susceptible to infection by human isolates of Borrelia burgdorferi; we obtained 100% infection. Isolation of the B. burgdorferi from different organs six months post infection causes a generalized infection thus demonstrating that borreliae persist in these animals for a long period. Spirochetemia was present for 14 days, apparently in two intervals. The Borrelia burgdorferi specific antibody titers increased with time after infection thus indicating the persistence of spirochetes. The intraperitoneal inoculation of the B. burgdorferi to six gerbils of groups A and B induced significant histopathologic changes in most of the major organ systems and their surrounding adipose and fibrous connective tissues. The infiltrates consisted mainly of lymphocytes and histiocytes. Various numbers of plasma cells, eosinophils and high numbers of mast cells were also present. Three further animals which served as controls displayed no histological signs of inflammation in any organ system. No significant differences were noted between the histopathological findings seen in the animals of groups A and B (infected with cells from subcultures no. 25 and with no. 5, respectively). The persistence of B. burgdorferi and the high number of organs involved with slight to severe signs of inflammation in this series can be compared to persistence and to the multiorgan involvement seen in human Lyme disease. Thus gerbils can serve as suitable experimental animals to study the pathogenesis of Lyme disease and the extent of organ damage caused by B. burgdorferi.

Entities:  

Mesh:

Year:  1990        PMID: 2076905     DOI: 10.1007/BF01646399

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  57 in total

1.  Antibiotic therapy of early European Lyme borreliosis and acrodermatitis chronica atrophicans.

Authors:  K Weber; V Preac-Mursic; U Neubert; R Thurmayr; P Herzer; B Wilske; G Schierz; W Marget
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

2.  Experimental Lyme arthritis in rats infected with Borrelia burgdorferi.

Authors:  S W Barthold; K D Moody; G A Terwilliger; P H Duray; R O Jacoby; A C Steere
Journal:  J Infect Dis       Date:  1988-04       Impact factor: 5.226

3.  Serological diagnosis of erythema migrans disease and related disorders.

Authors:  B Wilske; G Schierz; V Preac-Mursic; K Weber; H W Pfister; K Einhäupl
Journal:  Infection       Date:  1984 Sep-Oct       Impact factor: 3.553

4.  Isolation and characterization of the Lyme disease spirochete from the skin of patients with erythema chronicum migrans.

Authors:  B W Berger; M H Kaplan; I R Rothenberg; A G Barbour
Journal:  J Am Acad Dermatol       Date:  1985-09       Impact factor: 11.527

5.  Involvement of birds in the epidemiology of the Lyme disease agent Borrelia burgdorferi.

Authors:  J F Anderson; R C Johnson; L A Magnarelli; F W Hyde
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

6.  Infection of Syrian hamsters with Lyme disease spirochetes.

Authors:  R C Johnson; N Marek; C Kodner
Journal:  J Clin Microbiol       Date:  1984-12       Impact factor: 5.948

7.  Infantile multisystem inflammatory disease: another case of a new syndrome.

Authors:  F Lampert
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

8.  Unilateral blindness caused by infection with the Lyme disease spirochete, Borrelia burgdorferi.

Authors:  A C Steere; P H Duray; D J Kauffmann; G P Wormser
Journal:  Ann Intern Med       Date:  1985-09       Impact factor: 25.391

9.  Myositis caused by Borrelia burgdorferi: report of four cases.

Authors:  C D Reimers; D E Pongratz; U Neubert; A Pilz; G Hübner; M Naegele; B Wilske; P H Duray; J de Koning
Journal:  J Neurol Sci       Date:  1989-06       Impact factor: 3.181

10.  Lyme meningoencephalitis: report of a severe, penicillin-resistant case.

Authors:  M N Diringer; J J Halperin; R J Dattwyler
Journal:  Arthritis Rheum       Date:  1987-06
View more
  26 in total

Review 1.  Lyme Borreliosis: Is there a preexisting (natural) variation in antimicrobial susceptibility among Borrelia burgdorferi strains?

Authors:  Emir Hodzic
Journal:  Bosn J Basic Med Sci       Date:  2015-07-08       Impact factor: 3.363

2.  Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment.

Authors:  R K Straubinger; B A Summers; Y F Chang; M J Appel
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

3.  Ineffectiveness of tigecycline against persistent Borrelia burgdorferi.

Authors:  Stephen W Barthold; Emir Hodzic; Denise M Imai; Sunlian Feng; Xiaohua Yang; Benjamin J Luft
Journal:  Antimicrob Agents Chemother       Date:  2009-12-07       Impact factor: 5.191

4.  The NIH-3 immunodeficient mouse is a model for Lyme borreliosis myositis and carditis.

Authors:  D L Defosse; P H Duray; R C Johnson
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

5.  Homologous and heterologous Borrelia burgdorferi challenge of infection-derived immune rabbits using host-adapted organisms.

Authors:  E S Shang; X Y Wu; M A Lovett; J N Miller; D R Blanco
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

6.  Delineating Surface Epitopes of Lyme Disease Pathogen Targeted by Highly Protective Antibodies of New Zealand White Rabbits.

Authors:  Artem S Rogovskyy; Salvador Eugenio C Caoili; Yurij Ionov; Helen Piontkivska; Pavel Skums; Viachaslau Tsyvina; Alex Zelikovsky; Suryakant D Waghela
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

7.  Formation and cultivation of Borrelia burgdorferi spheroplast-L-form variants.

Authors:  V P Mursic; G Wanner; S Reinhardt; B Wilske; U Busch; W Marget
Journal:  Infection       Date:  1996 May-Jun       Impact factor: 3.553

8.  Passive immunizing activity of sera from mice infected with Borrelia burgdorferi.

Authors:  S W Barthold; L K Bockenstedt
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

9.  Antigenic stability of Borrelia burgdorferi during chronic infections of immunocompetent mice.

Authors:  S W Barthold
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

10.  Effectiveness of antimicrobial treatment against Borrelia burgdorferi infection in mice.

Authors:  K D Moody; R L Adams; S W Barthold
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.